Surveillance of viral pathogens in Australia: Rotavirus
DOI:
https://doi.org/10.33321/cdi.2003.27.79Abstract
For many years, a sentinel laboratory system, the Laboratory Virology and Serology Reporting Scheme (LabVISE) has been collecting data on viral pathogens of public health importance in Australia. This report is one in a series of articles focussing on the epidemiology and public health aspects of viruses and viral groups under surveillance by LabVISE, which are of current public health interest.
Downloads
References
Bishop R, Davidson G, Holmes I, BJR. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973;2:1281-1283.
Parashar U, Hummelman E, Bresee J, Miller M, Glass R. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-572.
Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed rotavirus vaccine challenges initial conclusions. J Infect Dis 2003;187:1301-1308.
Carlin JB, Chondros P, Masendycz P, Bugg HC, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust 1998;168:252-256.
Chin J ed. Control of Communicable Diseases Manual. 17th edn. Washington: American Public Health Association; 2000.
Cunliffe NA, Bresee JS, Gentsch JR, Glass RI, Hart CA. The expanding diversity of rotaviruses. Lancet 2002;359:640-642.
Offit P, Clark H. Rotavirus. In: Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th edn. New York: Churchill Livingstone; 1995. p. 1448-1455.
Rodger S, Bishop R, Birch C, McLean B, Holmes I. Molecular epidemiology of human rotaviruses in Melbourne, Australia, from 1973 to 1979, as determined by electrophoresis of genome ribonucleic acid. J Clin Microbiol 1981;13:272-278.
Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: A prospective longitudinal study in young children. N Engl J Med 1983;309:72-76.
Widdowson MA, van Doornum GJ, van der Poel WH, de Boer AS, van de Heide R, Mahdi U, et al. An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: Investigation using both epidemiological and microbiological methods. Infect Control Hosp Epidemiol 2002;23:665-670.
Sharma R, Hudak ML, Premachandra BR, Stevens G, Monteiro CB, Bradshaw JA, et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002;21:1099-1105.
Parashar U, Bresee J, Gentsch J, Glass R. Rotavirus. Emerg Infect Dis 1998;4:561-570.
Gianino P, Mastretta E, Longo P, Laccisaglia A, Sartore M, Russo R, et al. Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. J Hospital Infection 2002;50:13-17.
Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow Al, Carter-Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-1028.
Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, et al. Protective immunity after natural rotavirus infection: A community cohort study of newborn children in Guinea-Bissau, West Africa. J Infect Dis 2002;186:593-597.
Griffin DD, Fletcher M, Levy ME, Ching-Lee M, Nogami R, Edwards L, et al. Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis 2002;185:1502-1505.
Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P, Prasad BVV, et al. Inhibition of rotavirus replication by a non-neutralising, rotavirus VP6-specific IgA mAb. J Clin Invest 2002;109:1203-1213.
Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: An overview. Clin Infect Dis 2002;34:1351-1361.
Bishop R. Natural history of human rotavirus infection. Arch Virol 1996;12 Suppl:119-128.
Mohan P, Haque K. Oral immunoglobulin for the treatment of rotavirus infection in low birth weight infants. Cochrane Database Syst Rev 2003;1:cd003742.
Davidson GP, Whyte PB, Daniels E, Franklin K, Nunan H, McCloud PI, et al. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 1989;2:709-712.
Hilpert H, Brussow H, Mietens C, Sidoti J, Lerner L, Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987;156:158-166.
Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula L, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999;104:e64.
Mastretta E, Longo P, Laccisaglia A, Balbo L, Russo R, Mazzaccara A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002;35:527-531.
Top of page
World Health Organization. Rotavirus vaccines: WHO position paper. Weekly Epidemiological Record 1999;74:33-40.
Perez Mato S, Perrin K, Scardino D, Begue RE. Evaluation of rotavirus vaccine effectiveness in a pediatric group practice. Am J Epidemiol 2002;156:1049-1055.
Intussusception among recipients of rotavirus vaccine -United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48:577-581.
Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants [review]. J Infect Dis 1996;174:S73-S80.
Clements-Mann M, Makhene M, Mrukowicz J, Wright P, Hoshino Y, Midthun K, et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine 1999;17:2715-2725.
Hoshino Y, Jones RW, Ross J, Kapikian AZ. Construction and characterization of rhesus monkey rotavirus (mmu18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines. Vaccine 2003;21:3003-3010.
Bernstein DI, Sack DA, Reisinger K, Rothstein E, Ward RL. Second year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants. J Infect Dis 2002;186:1487-1489.
Barnes GL, Lund JS, Mitchell SV, de Bruyn L, Piggford L, Smith AL, et al. Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 2002;20:2950-2956.
Carlin JB, Jackson T, Lane T, Bishop RF, Barnes GL. Cost effectiveness of rotavirus vaccination in Australia. Aust N Z J Public Health 1999;23:611-616.
Armstrong P. Rotaviral gastroenteritis in the NT: a description of the epidemiology 1995-2001 and future directions for research. Northern Territory Disease Control Bulletin 2001;8:1-5.
Masendycz P, Bogdanovic-Sakran N, Kirkwood C, Bishop R, Barnes G. Report of the Australian Rotavirus Surveillance Program 2000/2001. Commun Dis Intell 2001;25:143-146.
Williams G, Zerna L. Rotavirus outbreak in central Australia. Aust Infect Contr 2002;7:51-58.
Barnes G, Uren E, Stevens K, Bishop R. Etiology of acute gastroenteritis in hospitalised children in Melbourne, Australia, from April 1980 to March 1993. J Clin Microbiol 1998;36:133-138.
Masendycz P, Palombo E, Barnes G, Bishop R. Rotavirus diversity: What surveillance will tell us. Commun Dis Intell 1999;23:198-199.
Kirkwood C, Bogdanovic-Sakran N, Palombo E, Masendycz P, Bugg H, Barnes G, et al. Genetic and antigenic characterization of rotavirus serotype G9 strains isolated in Australia between 1997 and 2001. J Clin Microbiol 2003;41:3649-3654.
Cunliffe NA, Dove W, Bunn JEG, Ramadam MB, Nyangao JWO, Riveron RL, et al. Expanding global distribution of rotavirus serotype G9: Detection in Libya, Kenya and Cuba. Emerg Infect Dis 2001;7:890-892.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2003 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
